Pangolins’ genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins’ vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company,

November 20, 2024

‘Tootsie Roll’ Introduced for Leaky Transcatheter Heart Valves

Operators reported the initial success of a novel transcatheter technique for treating complex paravalvular leaks (PVLs) after transcatheter aortic valve replacement (TAVR) or transcatheter mitral

January 19, 2024

Teva, Sanofi conclude collaboration deal for anti TL1A therapy

Share this article TEV ‘574 is under assessment in Phase IIb clinical studies to treat ulcerative colitis and Crohn’s disease. Credit: sdecorated / Shutterstock.com. Teva

December 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.